Christian Clausen has not added Biography.
If you are Christian Clausen and would like to personalize this page please email our Author Liaison for assistance.
Transient p53 suppression increases reprogramming of human fibroblasts without affecting apoptosis and DNA damage.
Stem cell reports Sep, 2014 | Pubmed ID: 25241739
Low-molecular-weight carbohydrate Pentaisomaltose may replace dimethyl sulfoxide as a safer cryoprotectant for cryopreservation of peripheral blood stem cells.
Transfusion May, 2016 | Pubmed ID: 26991781
Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a P301L mutation in microtubule-associated protein tau (MAPT).
Stem cell research Jan, 2016 | Pubmed ID: 27345788
Induced pluripotent stem cells (iPSCs) derived from a patient with frontotemporal dementia caused by a R406W mutation in microtubule-associated protein tau (MAPT).
Stem cell research Jan, 2016 | Pubmed ID: 27345789
Induced pluripotent stem cells (iPSCs) derived from a pre-symptomatic carrier of a R406W mutation in microtubule-associated protein tau (MAPT) causing frontotemporal dementia.
Stem cell research Jan, 2016 | Pubmed ID: 27345791
Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.
Stem cell research Jan, 2016 | Pubmed ID: 27345792
Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific heterozygous mutation in CHMP2B.
Stem cell research Jul, 2016 | Pubmed ID: 27558613
Generation of a human induced pluripotent stem cell line via CRISPR-Cas9 mediated integration of a site-specific homozygous mutation in CHMP2B.
Stem cell research Jul, 2016 | Pubmed ID: 27558614
Generation of induced pluripotent stem cells derived from a 77-year-old healthy woman as control for age related diseases.
Stem cell research Nov, 2016 | Pubmed ID: 27789407
Generation of an isogenic, gene-corrected iPSC line from a symptomatic 57-year-old female patient with frontotemporal dementia caused by a P301L mutation in the microtubule associated protein tau (MAPT) gene.
Stem cell research Nov, 2016 | Pubmed ID: 27789409
Induced pluripotent stem cells (iPSCs) derived from a symptomatic carrier of a S305I mutation in the microtubule-associated protein tau (MAPT)-gene causing frontotemporal dementia.
Stem cell research Nov, 2016 | Pubmed ID: 27789411
Generation of an isogenic, gene-corrected iPSC line from a symptomatic 59-year-old female patient with frontotemporal dementia caused by an R406W mutation in the microtubule associated protein tau (MAPT) gene.
Stem cell research Nov, 2016 | Pubmed ID: 27934586
Generation of an isogenic, gene-corrected iPSC line from a pre-symptomatic 28-year-old woman with an R406W mutation in the microtubule associated protein tau (MAPT) gene.
Stem cell research Nov, 2016 | Pubmed ID: 27934590
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B.
Stem cell reports Mar, 2017 | Pubmed ID: 28216144
Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) - the Hot Start experience.
Stem cell research Apr, 2017 | Pubmed ID: 28334554
Human Embryonic Stem Cell-Derived Cardiomyocytes Self-Arrange with Areas of Different Subtypes During Differentiation.
Stem cells and development Nov, 2017 | Pubmed ID: 28795648
Pentaisomaltose, an Alternative to DMSO. Engraftment of Cryopreserved Human CD34 Cells in Immunodeficient NSG Mice.
Cell transplantation Sep, 2018 | Pubmed ID: 30056762
TAFA2 Induces Skeletal (Stromal) Stem Cell Migration Through Activation of Rac1-p38 Signaling.
Stem cells (Dayton, Ohio) Mar, 2019 | Pubmed ID: 30485583
Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line.
Stem cell research Jan, 2019 | Pubmed ID: 30660866
Corrigendum to "Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line" [Stem Cell Res. 34/1873-5061 (2019) 101349-55].
Stem cell research Oct, 2020 | Pubmed ID: 32971461
Generation of a set of isogenic iPSC lines carrying all APOE genetic variants (Ɛ2/Ɛ3/Ɛ4) and knock-out for the study of APOE biology in health and disease.
Stem cell research Apr, 2021 | Pubmed ID: 33556820
Generation of two gene edited iPSC-lines carrying a DOX-inducible NGN2 expression cassette with and without GFP in the AAVS1 locus.
Stem cell research Apr, 2021 | Pubmed ID: 33610017
Scalable expansion of iPSC and their derivatives across multiple lineages.
Reproductive toxicology (Elmsford, N.Y.) Sep, 2022 | Pubmed ID: 35595152
Human iPSC-derived hepatocytes in 2D and 3D suspension culture for cryopreservation and in vitro toxicity studies.
Reproductive toxicology (Elmsford, N.Y.) Aug, 2022 | Pubmed ID: 35598806
Jeanette Wihan1,
Isabell Karnatz1,
Isabelle Sébastien1,
Ralf Kettenhofen1,
Benjamin Schmid2,
Christian Clausen2,
Benjamin Fischer1,
Rachel Steeg3,
Heiko Zimmermann1,4,5,6,
Julia C. Neubauer1,4
1Fraunhofer Project Center for Stem Cell Process Engineering, Fraunhofer Institute for Biomedical Engineering IBMT,
2, Bioneer A/S,
3, Fraunhofer UK Research Ltd, Technology and Innovation Centre,
4, Fraunhofer Institute for Biomedical Engineering IBMT,
5Department of Molecular and Cellular Biotechnology, Saarland University,
6Facultad de Ciencias del Mar, Universidad Católica del Norte
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved